Why Was Injectable Bacitracin Discontinued?
•
4 min read
In 2020, the U.S. Food and Drug Administration (FDA) requested the withdrawal of bacitracin for injection from the market. This action stemmed from a determination that the drug's risks, including serious kidney damage, far outweighed its benefits for its only approved use. However, this recall does not apply to the topical or ophthalmic formulations, which remain widely available over-the-counter.
